Related Experiment Video
Updated: Jan 15, 2026
Author Spotlight: Developing a Point-of-Care Hemoglobin Estimation Method for Anemia Management
Published on: January 19, 2024
Access to essential medicines in aspirational districts of India; A multi-site cross sectional study
Bikash Ranjan Meher1, Biswa Mohan Padhy1, Rashmi Ranjan Mohanty2
1Department of Pharmacology, All India Institute of Medical Sciences, Bhubaneswar, Odisha, India.
Introduction:
Inequitable access to essential medicines (EMs) is a big challenge for optimal delivery of health care in a country like India. Baseline data is essential to develop effective public health policy to facilitate equitable access to EMs. The primary purpose of this research was to investigate the price, availability, and affordability EMs in the aspirational districts of Odisha using WHO/HAI methodology.
Materials And Methods:
The study was carried out in 25 public health facilities and 25 private pharmacies. Data on availability and price of EMs was collected from both public health facilities and private pharmacies. Prices were compared to an international reference price (expressed as median price ratio-MPR). Treatment affordability also was calculated for surveyed EMs.
Results:
The overall percent availability of lowest price generics (LPGs) was 62% in the public health facilities and 58% in private pharmacies. The procurement price of surveyed medicines for public health facilities was 0.28 (IQR, 0.17, 0.50) times of IRP, whereas price charged to patients for the same in retail pharmacies was 1.34 (IQR, 0.71 to 2.4) of IRP. Most of the surveyed medicines in private pharmacies required for acute conditions were affordable except amoxicillin/clavulanic acid 625 mg tablet that was slightly unaffordable, with a single course of treatment costing up to 1.21 days of wages.
Conclusion:
This study revealed that overall availability of surveyed EMs in both public sector facilities and private pharmacies was optimal. Both procurement prices and prices charged to patients of surveyed medicines were reasonable in comparison to IRP. Availability of EMs has improved and many medicines are now affordable. These data have significant policy implications that could help in amending policies to further increase the access to EMs for patients residing in remote areas of the country.
More Related Videos
19:57An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings
Published on: March 30, 2014
09:33Visualizing Field Data Collection Procedures of Exposure and Biomarker Assessments for the Household Air Pollution Intervention Network Trial in India
Published on: December 23, 2022
Related Concept Videos
01:09Bioequivalence of Drugs: Drugs with Multiple Indications
01:26Methods Of Healthcare Delivery System
Managed Care System:
The managed care system is designed to control the cost while maintaining the quality of care. The patient's care from admission to discharge is planned by the primary care provider or the case manager, also known as the gatekeeper. In a managed care system, the number of care providers is...
01:19Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
01:30Primary Healthcare Services
In 1978, international leaders convened in Alma-Ata, Kazakhstan, for what would be a pivotal event in global health. The Alma-Ata Declaration was the first to call...
01:15Bioavailability Study Design: Healthy Subjects Versus Patients
01:11Bioavailability Study Design: Single Versus Multiple Dose Studies